REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Glaxosmithkline Pakistan Limited (Pakistan)

Main Activities: Medicinal and Botanical Manufacturing | Biological Product (except Diagnostic) Manufacturing
Full name: Glaxosmithkline Pakistan Limited Profile Updated: April 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Glaxosmithkline (GSK) Pakistan Limited is the Pakistani division of the science orientated global healthcare company Glaxosmithkline. It offers vaccines, medicines and consumer healthcare products. The Pakistani company was incorporated in 2001 through the merger of SmithKline and French of Pakistan, Beecham (Pakistan) Limited and Glaxo Wellcome (Pakistan) Limited, which has been operating in Pakistan for over five decades. GSK Pakistan is active in the production of medicines in various therapeutic classes, mainly anti-infective, respiratory, vaccines, dermatological, gastrointestinal, analgesics, oncology, urology, central nervous system, cardiovascular and vitamin therapy.

Headquarters
35 - Dockyard Road, West Wharf
Karachi; Sindh; Postal Code: 74000

Contact Details: Purchase the Glaxosmithkline Pakistan Limited report to view the information.

Website: http://www.pk.gsk.com

Basic Information
Total Employees:
Purchase the Glaxosmithkline Pakistan Limited report to view the information.
Outstanding Shares:
Purchase the Glaxosmithkline Pakistan Limited report to view the information.
Financial Auditors:
Purchase the Glaxosmithkline Pakistan Limited report to view the information.
Incorporation Date:
1949
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
82.59%
Purchase this report to view the information.
5.98%
Purchase this report to view the information.
3.67%
Purchase this report to view the information.
2.88%
Purchase this report to view the information.
0.13%
Company Performance
Financial values in the chart are available after Glaxosmithkline Pakistan Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PKR. Absolute financial data is included in the purchased report.
Net sales revenue
18.69%▲
Total operating revenue
21.8%▲
Operating profit (EBIT)
-59.56%▼
EBITDA
-50.39%▼
Net Profit (Loss) for the Period
-78.32%▼
Total assets
7.28%▲
Total equity
2.96%▲
Operating Profit Margin (ROS)
-8.01%▼
Net Profit Margin
-4.81%▼
Return on Equity (ROE)
-9.24%▼
Quick Ratio
-0.14%▼
Cash Ratio
-0.12%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo